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ABSTRACT 
Objective: The present investigation was designed to study the inhibitory effects of methanolic leaf extract of Ocimum canum (O. canum) on α-
glucosidase using in vitro model followed by an assessment of bioactive compounds. 
Methods: The methanolic leaf extract was prepared by Soxhlet extraction method and partially purified by thin layer chromatography (TLC). Each 
band was subjected to α-glucosidase inhibition study. The positive bands were further characterized by high-performance liquid chromatography 
(HPLC) and quadrupole time of flight (Q-TOF) micro mass spectrometer. 
Results: Out of the several combinations of solvent systems, toluene, ethyl acetate and formic acid combination in the ratio of 7:2:1 revealed 5 
bands on the TLC sheet. Among all the TLC bands, 2 bands (band A and B) showed the significant inhibitory effect on α-glucosidase activity. HPLC 
analysis of band A and B revealed the presence of two important polyphenolic compounds, namely rosmarinic acid (RA) and ursolic acid (UA). Q-
TOF micromass spectrometer analysis revealed the percentage availability of RA, caffeic acid, tartaric acid, quercetin and other polyphenolic 
components in the bioactive bands. 
Conclusion: The study revealed that methanolic leaf extract of O. canum exhibits potent inhibition of α-glucosidase activity. Inhibition of α-
glucosidase activity might be attributed to the presence of the polyphenolic compounds like RA and UA. Therefore, this finding can lead to the 
development of natural α-glucosidase inhibitors by the O. canum leaf extract. 
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INTRODUCTION 
Diabetes mellitus is a metabolic disorder characterized by 
hyperglycemia, which results from improper regulation of 
carbohydrate and lipid metabolism by insulin. The disorder causes 
considerable long-term complications and is also a major risk factor 
for cardiovascular diseases. Type-II diabetes is more prevalent than 
type I and is caused by an imbalance in insulin secretion. 
Postprandial hyperglycemia is an important symptom of type II 
diabetes and is one of the primary anti-diabetic targets. Treatment 
of postprandial hyperglycemia can be achieved by inhibiting key 
carbohydrate hydrolyzing enzymes like α-glucosidase and α-
amylase [1, 2]. Alpha glucosidase is a membrane-bound enzyme 
which facilitates absorption of glucose by the small intestine. The 
inhibition of α-glucosidase in the small intestine delays the rate of 
hydrolytic cleavage of oligosaccharides. The process of digestion 
spreads to the lower part of small intestine, which delays the overall 
absorption rate of glucose into the blood and decreases the 
postprandial rise of blood sugar [1]. 
Herbal drugs are widely used in the treatment of diabetes with 
lesser side effects [3, 4] due to their availability and cost-
effectiveness. Hence, screening of medicinal plants for inhibition of 
carbohydrate-hydrolyzing enzymes holds an enormous potential for 
developing new drugs for the treatment of diabetes. 
Among different medicinal plants, the genus ocimum has a strong 
therapeutic potential [5]. They are distributed throughout the Indian 
subcontinent and most of them are traditionally used for the 
treatment of ailments such as cardiovascular disorders, diabetes, 
fungal infections, bronchitis, bronchial asthma, malaria, diarrhoea 
and arthritis [6]. O. canum belongs to the family Lamiaceae and is 
traditionally used in West Africa for the treatment of hyperglycemia 
[7]. Aqueous leaf extract of this plant was reported as having anti-
hyperglycemic property [8]. The aqueous extract of both fresh and 
dried leaves of O. canum lowers fasting blood glucose levels as well 
as the body weight of genetically diabetic mice [8]. 
Earlier reports suggest that the presence of phenolic acids like 
rosmarinic acid might be responsible for the antihyperglycemic 
property of this plant [9]. Scarpatti and G Oriente (1958) have 
shown that RA is a polyphenol which is ubiquitously present in 
species of the Boraginaceae, the subfamily Nepetoideae of the family 
of Lamiaceae [10]. 
RA is also reported to be present in O. canum and several other 
Lamiaceae members [9]. UA is another important polyphenol 
reported from genus Ocimum exhibiting a wide range of 
pharmaceutical properties [11]. 
In the past few decades, substantial research work has been devoted 
to understanding the biological activities of phytochemicals. None of 
the research, however, fully demonstrates the mechanism which can 
be utilized to manage diabetes and associated complications. 
Moreover, not much focus was given to identifying exactly which 
constituents present in this plant aids in treating hyperglycemia. 
There are very few reports which concentrated on the effects of RA 
and UA on the α-glucosidase activity. Therefore, the present study 
aims to analyze the inhibitory effect of the leaf extracts of O. canum 
on the carbohydrate metabolizing enzyme and examines its 
correlation with the presence of polyphenolic compounds. 
MATERIALS AND METHODS 
Collection of plant material 
Seeds of O. canum were collected, identified and authenticated from 
the Institute of Integrated Ayurveda and Medicine, Yelhanka 
(13.1005 °N and 77.5940 °E), Bangalore. The authenticated voucher 
specimen of O. canum (voucher number: BUB/MB-BT/KM/O. c/01) 
was deposited in the Department of Microbiology and Bio-
technology, Bangalore University, Bangalore. 
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Plants were maintained for three months and leaves were harvested 
at full bloom. Leaves were weighed and air dried in paper bags at 
room temperature for 15 d. 
Preparation of leaf extract 
The dried leaf powder of O. canum 50g was extracted with 200 ml of 
methanol 95% v/v by a Soxhlet apparatus at 50 °C temperature for 
36 h. The process was repeated twice and the extract obtained was 
filtered and evaporated to dryness by a rotary evaporator (Superfit, 
R/150/22, India) at 40 °C [12]. The dried extract was weighed and 
kept at -20°C for further analysis. 
Chemicals used 
Dipotassium hydrogen phosphate and potassium dihydrogen 
phosphate for preparing phosphate buffer were purchased from 
Merck Millipore, Germany. Alpha-glucosidase and alpha-D gluco-
pyranoside (PNPG) was purchased from SRL, Mumbai. Sodium 
carbonate, methanol, toluene, ethyl acetate, formic acid, tetra-
hydrofuran, orthophosphoric acid and dimethyl sulphoxide (DMSO) 
were purchased from Himedia, Bengaluru. Silica Gel (GF-254 8x5) 
was purchased from Merck. Standard rosmaranic acid and ursolic 
acid were purchased from Sigma-Aldrich. 
Thin layer chromatography 
A hundred microlitre of the crude methanolic extract was applied on 
silica gel GF-254(Merck, 8x5 cm) plates. Toluene: ethyl acetate: 
formic acid (7:2:1v/v) was used as a developing solvent system. TLC 
bands were visualized under visible and UV light and retention 
factor (Rf) values were calculated. Each TLC band (1 mg) was 
collected and dissolved in 10% of dimethyl sulphoxide (HPLC 
grade), filtered and the samples were stored separately. Different 
concentrations of extract such as 50, 100, 150 and 200 μg/ml were 
prepared for the assessment of the inhibitory effect on α-glucosidase 
activity. 
Alpha-glucosidase inhibitory assay 
The α-glucosidase inhibitory activity was assayed as per the 
procedure of Kim et al. (2005) [13]. Alpha-D glucopyranoside 
(PNPG) in 0.1 M potassium phosphate buffer (pH 6.9) was used as a 
substrate. The enzyme solution (0.1 U/ml) was prepared in 0.01 M 
phosphate buffer (pH 6.0). The reaction mixture consisted of 
phosphate buffer, 0.25 ml of 0.5 mmol 4-nitrophenyl α-D-
glucopyranoside (PNPG), 0.1 ml α-glucosidase, and 100 µl of the 
sample. The reaction was carried out at 37 °C for 20 min and was 
stopped by adding 0.1 M sodium carbonate solution. The enzyme 
activity was monitored using spectrophotometer (UV-1800 
Shimadzu) at 400 nm by the estimation of p-nitrophenol released. 
All experiments were carried out in triplicate and the inhibitory 
effect of the extract on α-glucosidase was assessed and calculated as 
percent inhibition. 
HPLC of the bioactive bands 
HPLC was performed on bioactive bands and the system used was 
SPD-10Avp/10vvP (Shimadzu, Japan). It was carried out using a C18 
column (250x4.6 mm, 5 µm) as the stationary phase and methanol: 
tetrahydrofuran: 0.1% orthophosphoric acid (55:5:40 v/v) as the 
mobile phase at a flow rate 0.7 ml/min and a pressure of 139 
kgF/cm at a temperature of 40 °C. The TLC bands were sonicated 
and filtered through syringe filter before use. RA (≥ 98% HPLC 
Sigma-Aldrich) and UA (≥ 90% HPLC Sigma-Aldrich) used as a 
standard during HPLC analysis of polyphenolic compounds. The 
injection volume was 20 µl (1 mg/ml in methanol) and elutions were 
detected at 210 and 330 nm for RA and UA respectively [14]. 
Compounds were identified by comparing the retention time and 
absorption spectra with their standards. 
Mass spectrometer analysis of the bioactive bands 
Mass spectrometry was performed using a micromass Q-Tof-micro 
TM(Waters) operating in positive ion electrospray mode. The general 
conditions were the source temperature of 373 K, capillary voltage 
2.5 kV, cone voltage of 45V, syringe rate was 50 ul and the sample 
volume was 20 µl. Mass spectra were acquired and accumulated 
over 60 s and the spectra were scanned in the range of 100 to 1200 
m/z. The ions of interest (on the basis of m/z) were selected and 
deposited for collision with argon in the collision quadrupole. 
Collision gas pressure was tuned to generate extensive 
fragmentation of the ions under observation. 
RESULTS 
The inhibitory effect of the methanolic leaf extract of O. canum on α-
glucosidase activity and its relation to the polyphenol compounds 
present in the extract was analysed and the results are presented in 
fig. and tables. 
Thin layer chromatography 
Fig. 1 shows the TLC plate of the methanolic leaf extract. Among the 
different combinations of nonpolar solvents used, toluene: ethyl 
acetate: formic acid (7:3:1) combination showed the best separation 
of compounds. Five clearly separated bands were obtained. The Rf 
values of band A, B, C, D and E were found to be 0.5, 0.68, 0.73, 0.78 
and 0.85 respectively. 
 
 
Fig. 1: TLC of methanolic extract of Ocimum canum, with the 
solvent system, toluene: ethyl acetate and formic acid (7:2:1) 
 
Effect of Ocimum canum extract on α-glucosidase activity 
The α-glucosidase activity was found to be inhibited by the leaf 
extracts on a dose-dependent manner with a correlation of r2= 
0.929, (fig. 2). TLC band B displayed the maximum inhibition of α-
glucosidase activity followed by bands A, C and D, whereas band E 
did not show any inhibitory effect on the α-glucosidase activity (fig. 
2). The IC50 of band B was found to be 159.21 µg, followed by bands 
A, C and D which were found to be 191.53 µg, 430.03 µg and 498.00 
µg respectively. The IC50 values of different TLC bands are presented 
in table 1. 
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Fig. 2: Inhibitory activity of Ocimum canum leaf extract (TLC 
bands A, B, C and D) against the α-glucosidase activity. Results 
are mean±SD-standard deviation, (n=3) 
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Table 1: IC50 value of different TLC bands of Ocimum canum leaf 
extract 
S. No. Leaf extract IC50 
1 Band A 191.53 µg 
2 Band B 159.21 µg 
3 Band C 430.03 µg 
4 Band D 498.00 µg 
 
HPLC analysis of bioactive TLC bands 
Bioactive compounds of TLC bands A and B were confirmed by HPLC 
and results were presented in fig. 3, fig. 4, fig. 5, fig. 6, fig. 7 and fig. 8. 
HPLC analysis of the TLC bands showed the presence of RA and UA 
together with several other compounds. The RA was detected at 330 
nm after 5.45 min (fig. 3-5) which has an absorbance maximum at 
330 nm and a minimum at 265 nm. The percent yield of RA in the 
TLC bands A and B were found to be 0.067 and 0.079 respectively 
(table 2). The UA was detected at 210 nm after 12.55 min as shown 
in (fig. 6-8). The percent yield of UA in the TLC bands A and B were 
found to be 0.122 and 0.160 respectively (table 3). 
Mass spectrometer analysis of bioactive TLC bands 
TLC bands A and B were further characterized by mass spectrometer 
and results (mass spectrum) were presented in fig. 9 and fig. 10. 
Most of the compounds were common in both the bands but 
percentage availability of these compounds was different. In TLC 
band A predominant organic acids and phenolic compounds were 
observed as tartaric acid of m/z 149, the caffeic acid of m/z 179, 
quercetin of m/z 305 and RA of m/z 360 (fig. 9). In TLC band B the 
compounds were found to be the tartaric acid of m/z 149, the caffeic 
acid of m/z 179, quercetin of m/z 305, RA of m/z 360 RA of m/z 361 
(fig. 10). The percentage availability of quercetin (69 %) and RA 
(55%) in band B was found to be significantly higher than band A. 
 
 
Fig. 3: HPLC chromatogram of rosmarinic acid (RA) standard solution 
 
Fig. 4: HPLC chromatogram of rosmarinic acid (RA) present in the TLC band A of methanolic extract of Ocimum canum 
 
 
Fig. 5: HPLC chromatogram of rosmarinic acid (RA) present in the TLC band B of methanolic extract of Ocimum canum 
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Table 2: Quantification of rosmarinic acid (RA) present in the TLC bands of methanolic extract of Ocimum canum 
S. No. Compounds Conc (mg/ml) Ret. time (min) % yield 
1. RA (std.) 0.10 5.541 98 
2. Band A 10.00 5.431 0.067 
3. Band B 10.00 5.531 0.079 
Conc-concentration, Ret. time-retention time, Std-standard  
 
 
Fig. 6: HPLC chromatogram of ursolic acid (UA) standard solution 
 
 
Fig. 7: HPLC chromatogram of ursolic acid (UA) present in the TLC band A of methanolic extract of Ocimum canum 
 
 
Fig. 8: HPLC chromatogram of ursolic acid (UA) present in the TLC band B of methanolic extract of Ocimum canum 
 
Table 3: Quantification of ursolic acid (UA) present in the TLC bands of methanolic extract of Ocimum canum 
S. No. Compounds Conc (mg/ml) Ret time (min) % yield 
1. UA (std.) 0.10 12.55 95 
2. Band A 10.00 12.60 0.122 
3. Band B 10.00 12.71 0.160 
Conc-concentration, Ret. time-retention time, Std-standard 
Smita et al. 
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Fig. 9: Mass spectrum of TLC band A of methanolic extract of Ocimum canum 
 
 
Fig. 10: Mass spectrum of TLC band B of methanolic extract of Ocimum canum 
 
DISCUSSION 
Several plants have been shown to impart antihyperglycemic effect 
through the inhibition of carbohydrate-hydrolyzing enzymes in the 
small intestine [15-18]. It is evident from the present results that the 
methanolic leaf extract of O. canum inhibited α-glucosidase activity 
in vitro which is in agreement with the earlier reports [15-18]. As 
illustrated in the results the activity of α-glucosidase decreased with 
increased concentrations of the extract. TLC bands A and B of the 
leaf extract showed maximum enzyme inhibition when compared to 
bands C and D. Therefore, A and B bands were further subjected to 
HPLC to analyze the bioactive compounds. The yield percentage of 
RA obtained by HPLC method, and the availability percentage 
obtained by mass spectrometry in TLC band B was found to be 
higher with maximum inhibitory activity on α–glucosidase when 
compared to band A. This may be due to the fact that RA might be 
the lead compound that produces the enzyme inhibitory action. 
Further, the plant polyphenol reduces oxidative stress as well as 
inhibits carbohydrate hydrolyzing enzyme to control hyperglycemia 
[19, 20]. The RA being a derivative of polyphenol might also act as a 
strong antioxidant [21]. Previous studies revealed the therapeutic 
properties of RA, which mainly attributed to its potent antioxidative 
effects [22]. Initial studies have shown that RA controls plasma 
glucose by modulating SGLT1 trafficking to the intestinal brush 
border membrane in diabetic animals [23]. Antioxidant 
supplementation has been shown to improve the treatment of 
chronic diabetes. Consistent hyperglycemia and elevated levels of 
free fatty acids contribute to oxidative stress and cause progression 
of diabetes [24]. Therefore, antioxidants are frequently included in 
complementary therapeutics. The UA was detected as another 
bioactive compound in the leaf extract of O. canum, which is in 
concordance with the earlier reports [25, 26]. Silva et al.,(2008) [27] 
have shown that UA is detectably present in Ocimum basilicum, 
which is a triterpenoid and has been described as an anti-
inflammatory, hepatoprotective, antitumoral and antidiabetic agent 
[28]. Further, UA has been reported as an uncompetitive inhibitor of 
α-glucosidase [29]. It also stimulates glucose uptake through a cross-
talk between different signalling pathways, linking the P13K and 
MAPK pathways with Ca++-CaMKII network in translocation and 
GLUT4 expression in skeletal muscle [30]. 
The mass spectrometer method is a sensitive and selective way to 
identify polar organic compounds with acidic sites such as phenolic, 
organic acids and flavonoids [31]. Therefore, this method has been 
used to identify some of the important polyphenolic compounds 
present in O. canum methanolic extract. Hence, the inhibition of α-
glucosidase by O. canum extract may be presumed as a synergistic 
effect of RA, UA and other polyphenolic compounds. In addition, the 
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antioxidant property of RA and UA along with their α-glucosidase 
inhibitory property, these bioactive compounds might serve as 
potential candidates for the treatment of hyperglycemia. 
CONCLUSION 
Current studies provide an experimental justification to the 
traditional use of O. canum for the management of hyperglycemia 
and provide a preliminary understanding of the possible mechanism 
through which this plant may aid to overcome diabetes and 
associated complications. TLC bands A and B of the O. canum leaf 
extract showed significant inhibition of α-glucosidase and two 
important phenolic acids RA and UA were identified in these 
bioactive bands. Although the same compounds have been detected 
in both the bands but yield percentage and the availability 
percentage of RA in TLC band B was found to be higher, with 
maximum inhibitory activity on α–glucosidase. Therefore, band B 
could be the better choice to develop a therapeutic strategy for the 
treatment of hyperglycemia. 
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